8 Nov 2022 , 01:39 PM
Net profit of Suven Pharmaceuticals declined 25.70% to Rs 72.06 crore in the quarter ended September 2022 as against Rs 96.98 crore during the previous quarter ended September 2021. Sales declined 7.51% to Rs 278.40 crore in the quarter ended September 2022 as against Rs 300.99 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 278.40 | 300.99 | -8 |
| OPM % | 35.88 | 40.46 | – |
| PBDT | 110.51 | 143.10 | -23 |
| PBT | 98.48 | 133.93 | -26 |
| NP | 72.06 | 96.98 | -26 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
